Ebola Virus Net is the web resource for anyone interested in ebola. Ebola (Ebola hemorrhagic fever), is a severe, often fatal disease in humans and nonhuman primates such as monkeys, gorillas, and chimpanzees. Ebola is a rare and deadly disease caused by infection with a virus of the family Filoviridae, genus Ebolavirus. There are five identified Ebolavirus species, four of which have caused disease in humans. Ebola is found in several African countries. The first Ebola species was discovered in 1976 near the Ebola River in the Democratic Republic of the Congo. Since then, outbreaks have appeared sporadically in Africa. The largest outbreak to date was the epidemic in West Africa, which occurred from December 2013, to January 2016, with 28,646 cases and 11,323 deaths. Other outbreaks in Africa began in the Democratic Republic of the Congo in May 2017 and 2018. In July 2019, the World Health Organization declared the Congo Ebola outbreak a world health emergency.

When an infection does occur in humans, the virus can be spread to others through direct contact with the blood or body fluids of a person who is sick with Ebola, or through contact with objects that have been contaminated with the blood or body fluids of an infected person. Until recent, no vaccines were effective. In December 2016, Ebola was found to be 70–100% prevented by rVSV-ZEBOV vaccine, making it the first proven vaccine against the disease. More than 100,000 people have been vaccinated against Ebola as of 2019.

The objectives of Ebola Virus Net are to be the public and professional information resource for ebola and to serve as a network in the exchange of information and news related to ebola.

• 1st Ebola vaccine approved - ABC News
  Wed, 13 Nov 2019 17:34 GMT
• What it takes to protect gorillas from Ebola - National Geographic
  Fri, 15 Nov 2019 12:49 GMT
• The world finally has an approved vaccine against Ebola - Ars Technica
  Wed, 13 Nov 2019 00:14 GMT
• The Ebola Vaccine Is Now Officially Here With Approval In Europe - Forbes
  Tue, 12 Nov 2019 00:22 GMT
• At Ebola ground zero in DR Congo, new vaccine offers hope - Al Jazeera English
  Thu, 14 Nov 2019 18:02 GMT
• WHO: Biakato Mines region linked to recent Ebola cases - CIDRAP
  Wed, 13 Nov 2019 22:27 GMT
• Stopping Ebola - SETI Institute
  Mon, 18 Nov 2019 18:15 GMT
• USAID Funding Reaches $266 Million To Stop Ongoing Ebola Outbreak - Vax Before Travel
  Sat, 09 Nov 2019 08:00 GMT
• Can local and faith leaders help halt the spread of Ebola in DRC? - Aljazeera.com
  Sun, 17 Nov 2019 11:19 GMT
• Ebola crisis: New vaccine released in desperate attempt to finally halt deadly virus - Express.co.uk
  Fri, 15 Nov 2019 20:40 GMT
• The U.S. has stopped Ebola before. But it may never repeat that success. - The Washington Post
  Thu, 24 Oct 2019 07:00 GMT
• DRC President Says Ebola Outbreak Should Be Over By Year's End; A.U. Urges Partners To Increase Efforts To Stop Outbreak - Kaiser Family Foundation
  Mon, 18 Nov 2019 16:18 GMT
• WHO says Congo's Ebola outbreak still qualifies as a global emergency - ABC News
  Mon, 21 Oct 2019 07:00 GMT
• European commission gives green light to first Ebola vaccine - Chemistry World
  Mon, 18 Nov 2019 10:04 GMT
• Nutritional Care for Patients with Ebola Virus Disease in Ebola Treatment Units: Past and Current Experiences - Democratic Republic of the Congo - ReliefWeb
  Fri, 01 Nov 2019 07:00 GMT

• PRO/AH/EDR> Ebola update (108): Congo DR (NK, IT) cases, vaccine
  Wed, 13 Nov 2019 16:36:55 -0500
  Ebola -- DR Congo
  

• Efficient Expression and Processing of Ebola Virus Glycoprotein Induces Morphological Changes in BmN Cells but Cannot Rescue Deficiency of Bombyx Mori Nucleopolyhedrovirus GP64.